| MolName | [2-(3-morpholin-4-ylsulfonylanilino)-2-oxoethyl] (E)-3-[3-(4-bromophenyl)-1-phenylpyrazol-4-yl]prop-2-enoate |
| MolecularFormula | C30H27N4O6BrS |
| Smiles | O=C(COC(/C=C/c1cn(-c2ccccc2)nc1-c(cc1)ccc1Br)=O)Nc1cc(S(N2CCOCC2)(=O)=O)ccc1 |
| InChI | InChI=1S/C30H27BrN4O6S/c31-24-12-9-22(10-13-24)30-23(20-35(33-30)26-6-2-1-3-7-26)11-14-29(37)41-21-28(36)32-25-5-4-8-27(19-25)42(38,39)34-15-17-40-18-16-34/h1-14,19-20H,15-18,21H2,(H,32,36) |
| InChIK | GBVZIQCVRYGHIQ-UHFFFAOYSA-N |
| TotalMolweight | 651.536 |
| Molweight | 651.536 |
| MonoisotopicMass | 650.083467 |
| CLogP | 3.3812 |
| CLogS | -4.954 |
| H Acceptors | 10 |
| H Donors | 1 |
| TotalSurfaceArea | 446.77 |
| Relative PSA | 0.24064 |
| PolarSurfaceArea | 128.21 |
| Druglikeness | -2.4565 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | high |
| Nasty Functions | |
| Shape Index | 0.52381 |
| Fragments | 1 |
| Non HAtoms | 42 |
| NonCHAtoms | 12 |
| Electronegative Atoms | 12 |
| Rotatable Bond | 9 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 23 |
| Sp3Atoms | 8 |
| Symmetricatoms | 7 |
| Amides | 2 |
| Aromatic Nitrogens | 2 |
| StereoCon |
Click to Load Molecule:
1 - [2-(3-morpholin-4-ylsulfonylanilino)-2-oxoethyl] (E)-3-[3-(4-bromophenyl)-1-phenylpyrazol-4-yl]prop-2-enoate | 2 - [2-(3-morpholin-4-ylsulfonylanilino)-2-oxoethyl] (E)-3-[3-(4-bromophenyl)-1-phenylpyrazol-4-yl]prop-2-enoate